Linden Advisors’s Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 FRXB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-80,998
Closed -$114K 696
2021
Q2
$114K Buy
+80,998
New +$87K ﹤0.01% 754

Other funds holding FRXB.WS

Linden Advisors's FRXB.WS Position: Q3 2021 in Review

Linden Advisors sold out of Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (FRXB.WS) in Q3 2021, closing a stake of 80,998 shares — an estimated $114K sold.

Linden Advisors first reported a position in FRXB.WS in Q2 2021 and held it in 1 quarter. The position peaked at $114K in Q2 2021. 38 funds tracked by Wall St. Rank hold FRXB.WS as of Q3 2021.

  • Linden Advisors reported no remaining Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q3 2021 after selling out during the quarter.
  • Linden Advisors sold 80,998 Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q3 2021, an estimated $114K.
  • Linden Advisors first reported a position in Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q2 2021 and held it in 1 quarter.
  • Linden Advisors's Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $114K in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q3 2021.

Based on Linden Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.